The mainstream perspective:

The mainstream perspective:
- 23andMe's board resigned en masse due to differences with CEO Anne Wojcicki's plans to take the company private.
- The company has struggled financially and faced setbacks, including a data breach and declining DNA test sales.
- The independent directors resigned from the board, citing a lack of a fully financed proposal from CEO Anne Wojcicki to take the company private.
- 23andMe has struggled to find a profitable business model since going public in 2021.